MD3832G2 - Method for prophylaxis and treatment of sarcocystosis in cattle - Google Patents

Method for prophylaxis and treatment of sarcocystosis in cattle

Info

Publication number
MD3832G2
MD3832G2 MDA20080221A MD20080221A MD3832G2 MD 3832 G2 MD3832 G2 MD 3832G2 MD A20080221 A MDA20080221 A MD A20080221A MD 20080221 A MD20080221 A MD 20080221A MD 3832 G2 MD3832 G2 MD 3832G2
Authority
MD
Moldova
Prior art keywords
sarcocystosis
cattle
prophylaxis
treatment
day
Prior art date
Application number
MDA20080221A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3832F1 (en
Inventor
Думитру ЕРХАН
Штефан РУСУ
Тудор АНГЕЛ
Original Assignee
Институт Зоологии Академии Наук Молдовы
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Зоологии Академии Наук Молдовы filed Critical Институт Зоологии Академии Наук Молдовы
Priority to MDA20080221A priority Critical patent/MD3832G2/en
Publication of MD3832F1 publication Critical patent/MD3832F1/en
Publication of MD3832G2 publication Critical patent/MD3832G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to the veterinary medicine, particularly to a method for prophylaxis and treatment of sarcocystosis to cattle.The method includes subcutaneous administration of Ivomec preparation in a dose of 0,4 mg/kg of live weight on the 5-th and 12-th day or on the 25-th and 32-nd day from the beginning of grazing.The result of the invention consists in increasing the efficiency of sarcocystosis prophylaxis and treatment to cattle.
MDA20080221A 2008-08-14 2008-08-14 Method for prophylaxis and treatment of sarcocystosis in cattle MD3832G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080221A MD3832G2 (en) 2008-08-14 2008-08-14 Method for prophylaxis and treatment of sarcocystosis in cattle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080221A MD3832G2 (en) 2008-08-14 2008-08-14 Method for prophylaxis and treatment of sarcocystosis in cattle

Publications (2)

Publication Number Publication Date
MD3832F1 MD3832F1 (en) 2009-02-28
MD3832G2 true MD3832G2 (en) 2009-12-31

Family

ID=40427758

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080221A MD3832G2 (en) 2008-08-14 2008-08-14 Method for prophylaxis and treatment of sarcocystosis in cattle

Country Status (1)

Country Link
MD (1) MD3832G2 (en)

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Ironim Şuteu, Vasile Cozma. Parazitologie Clinică Veterinară. România, Cluj-Napoca, 2007, p. 189 *
Şuteu, Vasile Cozma. Parazitologie Clinică Veterinară. România Cluj-Napoca 2007, p. 189 *
Найти слова <URL:http://www.CNSHB.ru/AKDiL/0006/base/RS/000866.shtm...> Yandex:4 *
САРКОЦИСТОЗ (Sarcocystosis) жи­вотных, хронич. инвазионная болезнь, вызываемая простейшими из рода Sarcocystis, *
характеризующаяся образованием в мышечной ткани цист (мишеровые мешочки). ... *

Also Published As

Publication number Publication date
MD3832F1 (en) 2009-02-28

Similar Documents

Publication Publication Date Title
MX2010002498A (en) Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol.
AR124500A2 (en) INCREASED BIOAVAILABILITY OF THE DRUG IN NALTREXONE THERAPY
MX2022003072A (en) Use of pridopidine for treating functional decline.
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington&#39;s disease
MX2010002735A (en) Titration package for neramexane and its use in the treatment of an inner ear disorder.
EP4464375A3 (en) Methods of treatment using single doses of oritavancin
EP2708256A3 (en) Device and method for delivery of a medicament
NZ617397A (en) Pth-containing therapeutic/prophylactic agent for osteoporosis, characterized in that pth is administered once a week at unit dose of 100 to 200 units
EP4578461A3 (en) Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa
WO2012042197A3 (en) Low dose pharmaceutical composition comprising zanamivir
MX341660B (en) Ghrelin receptor agonist for treatment of dyscrasia.
MX2008011020A (en) Imidazole compounds having pharmaceutical activity towards the sigma receptor.
AR079000A1 (en) ANTI-BANK THERAPY AIMED AT CANCEROSA MOTHER RESISTANT DRUG CELLS
MD3422G2 (en) Method of prophylaxis and treatment of gallinaceae knemidokoptosis
MD3832F1 (en) Method for prophylaxis and treatment of sarcocystosis to cattle
JOP20170044B1 (en) Pharmaceutical composition comprising recombinant hgh for the treatment of growth hormone deficiency
AR080541A1 (en) TREATMENT FOR ENDOMETRIOSIS
MX2012005497A (en) Tivozanib and temsirolimus in combination.
WO2008045528A3 (en) Methods and compositions for the treatment of cancer
MX2021007324A (en) Oral therapy using 6,8-bis-benzylthio-octanoic acid.
RU2007100833A (en) METHOD FOR TREATING INFECTIOUS FACILITY OF THE FACIAL NERVE IN THE ACUTE PERIOD
RU2007129408A (en) METHOD OF GROWING PIGS IN THE PERIOD OF FEEDING
RU2013154562A (en) METHODS AND COMPOSITIONS FOR PRESERVING THE BEAUTY BODY WEIGHT IN THE PROCESS OF SLIMMING
RU2008152690A (en) METHOD FOR TREATING ANIMALS IN POST-PERMANENT ENDOMETRITIS
UA92803C2 (en) Treatment of trichostrongylus invasions of digestive tract of ruminants

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees